Can Cosentyx (secukinumab) patients get live vaccines?
Cosentyx (secukinumab) is an immune-modulating biologic that blocks interleukin-17A signaling. Because it can affect immune function, live vaccines are generally avoided while on treatment.
What counts as a “live vaccine”?
Live vaccines contain a weakened form of a germ that can still replicate. Common examples include measles-mumps-rubella (MMR), varicella (chickenpox), and the live nasal influenza vaccine.
What’s the practical rule for timing before or after Cosentyx?
The usual clinical approach is:
- Avoid giving live vaccines during Cosentyx therapy.
- If a live vaccine is needed, it is typically given before starting biologic treatment, with enough time for the vaccine to work.
- After stopping treatment, clinicians typically wait a period before giving a live vaccine to allow the medication’s immune effects to fade.
Exact timing can vary based on the specific product labeling and the patient’s treatment plan, so patients should confirm the schedule with their prescriber.
Why are live vaccines a concern with Cosentyx?
Live vaccines rely on the body’s immune response to control replication of the vaccine strain. With immunomodulatory therapies like IL-17 inhibitors, there is concern the vaccine could replicate more than intended and cause infection, or the immune response could be altered.
Are inactivated or non-live vaccines okay?
Non-live vaccines (like most routine vaccines that are inactivated, recombinant, or protein-based) are generally the safer option during Cosentyx treatment. Patients can usually receive these, but should still coordinate with their clinician or immunization provider.
Who should patients ask?
Ask the prescribing dermatologist/rheumatologist and the vaccination provider. They can check:
- the patient’s current Cosentyx dose and treatment timing,
- whether the vaccine is live or non-live,
- and whether any other immunosuppressing medicines are being used at the same time.
Sources
I don’t have the specific Cosentyx (secukinumab) vaccine-labelling text in the provided materials, so I can’t cite an authoritative statement for the exact “do/don’t” wording or timing interval. If you share your country (US/EU/UK/other) or the product label you’re using, I can align the answer to that labeling.